BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo S, Bai X, Liu Y, Shi S, Wang X, Zhan Y, Kang X, Chen Y, An H. Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma. Front Pharmacol 2021;12:643489. [PMID: 33935737 DOI: 10.3389/fphar.2021.643489] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D, Jeandet P. Mechanistic Insights into the Pharmacological Significance of Silymarin. Molecules 2022;27:5327. [PMID: 36014565 DOI: 10.3390/molecules27165327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Bond KH, Sims-lucas S, Oxburgh L. Targets for Renal Carcinoma Growth Control Identified by Screening FOXD1 Cell Proliferation Pathways. Cancers 2022;14:3958. [DOI: 10.3390/cancers14163958] [Reference Citation Analysis]
3 Bai X, Li S, Liu X, An H, Kang X, Guo S. Caffeic Acid, an Active Ingredient in Coffee, Combines with DOX for Multitarget Combination Therapy of Lung Cancer. J Agric Food Chem 2022. [PMID: 35772797 DOI: 10.1021/acs.jafc.2c03009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Okuyama K, Yanamoto S. TMEM16A as a potential treatment target for head and neck cancer. J Exp Clin Cancer Res 2022;41:196. [PMID: 35668455 DOI: 10.1186/s13046-022-02405-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bai X, Liu X, Li S, An H, Kang X, Guo S. Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer. J Agric Food Chem 2022. [PMID: 35298888 DOI: 10.1021/acs.jafc.1c08375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Romanucci V, Pagano R, Lembo A, Capasso D, Di Gaetano S, Zarrelli A, Di Fabio G. Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines. Molecules 2022;27:1702. [DOI: 10.3390/molecules27051702] [Reference Citation Analysis]
7 Shi S, Ma B, Sun F, Qu C, Li G, Shi D, Liu W, Zhang H, An H. Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity. J Biol Chem 2022;298:101731. [PMID: 35176281 DOI: 10.1016/j.jbc.2022.101731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Arreola J, Pérez-cornejo P, Segura-covarrubias G, Corral-fernández N, León-aparicio D, Guzmán-hernández ML. Function and Regulation of the Calcium-Activated Chloride Channel Anoctamin 1 (TMEM16A). Handbook of Experimental Pharmacology 2022. [DOI: 10.1007/164_2022_592] [Reference Citation Analysis]
9 Guo S, Bai X, Shi S, Deng Y, Kang X, An H. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. Int J Mol Sci 2021;22:10930. [PMID: 34681590 DOI: 10.3390/ijms222010930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Addeo R. Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer. J Exp Pharmacol 2021;13:901-3. [PMID: 34611448 DOI: 10.2147/JEP.S326871] [Reference Citation Analysis]
11 Rugamba A, Kang DY, Sp N, Jo ES, Lee JM, Bae SW, Jang KJ. Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells. Cells 2021;10:1632. [PMID: 34209829 DOI: 10.3390/cells10071632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]